Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $69.7 million.

  • Cellebrite DI's Total Non-Current Liabilities rose 2018.1% to $69.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.7 million, marking a year-over-year increase of 2018.1%. This contributed to the annual value of $59.0 million for FY2024, which is 7588.51% down from last year.
  • Latest data reveals that Cellebrite DI reported Total Non-Current Liabilities of $69.7 million as of Q3 2025, which was up 2018.1% from $69.0 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Total Non-Current Liabilities ranged from a high of $359.5 million in Q2 2024 and a low of $41.4 million during Q3 2021
  • In the last 5 years, Cellebrite DI's Total Non-Current Liabilities had a median value of $127.9 million in 2022 and averaged $153.6 million.
  • Per our database at Business Quant, Cellebrite DI's Total Non-Current Liabilities skyrocketed by 46644.91% in 2021 and then crashed by 8175.73% in 2025.
  • Cellebrite DI's Total Non-Current Liabilities (Quarter) stood at $226.6 million in 2021, then crashed by 46.3% to $121.7 million in 2022, then soared by 101.27% to $244.8 million in 2023, then tumbled by 75.89% to $59.0 million in 2024, then grew by 18.07% to $69.7 million in 2025.
  • Its last three reported values are $69.7 million in Q3 2025, $69.0 million for Q2 2025, and $58.6 million during Q1 2025.